This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Healthcare Trust of America, One of the Best Risk-Adjusted REITs

As a REIT gets bigger (or added to an index) investors must increase their investment in these companies. Interestingly, many active investment advisors are measured against these indexes and view a company's inclusion as a signal to pay attention to them.

That's exactly what's happening now with Healthcare Trust of America and in June HTA will unlock more shares (from its previous non-listed REIT shareholder pool) and I suspect that the investment appeal will increase. We're already seeing that now...

When Healthcare Trust of America went public in June, it was not owned by any institution or included in any index, limiting its investment appeal.

That has changed significantly since. Last fall, HTA's stock was added to several REIT indexes -- notably the MSCI US REIT Index and the Wilshire Real Estate Index. Institutional shareholders have also taken note, and increased their overall ownership stake in the company.

Healthcare Trust of America volume is averaging around one million shares a day and that should continue as the company is expected to be added to several more indexes over the next year which should further increase investor demand.



Healthcare Trust of America should continue to be a top performer in 2013 driven by the continued demand in high-quality income and strong capital appreciation. The stock is trading at $11.61 a share with a 4.95% dividend yield. My target price is $13.50.

At the time of publication the author held no positions in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
HTA $26.07 0.00%
AAPL $129.69 3.60%
FB $78.99 0.00%
GOOG $537.90 0.00%
TSLA $226.03 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs